B of A Securities Downgrades Molina Healthcare to Underperform, Announces $439 Price Target
B of A Securities Downgrades Molina Healthcare to Underperform, Announces $439 Price Target
Bof A證券將莫利納醫療的評級下調至表現不佳,宣佈目標股價爲439美元
B of A Securities analyst Kevin Fischbeck downgrades Molina Healthcare (NYSE:MOH) from Neutral to Underperform and announces $439 price target.
B of A Securities分析師凱文·菲施貝克將莫利納醫療保健(紐約證券交易所代碼:MOH)的評級從中性下調至表現不佳,並宣佈了439美元的目標股價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。